Archer Research
Generated 5/11/2026
Executive Summary
Archer Research is a Belgium-based full-service Contract Research Organization (CRO) specialized in supporting medical device companies with clinical research and regulatory compliance, particularly under the EU Medical Device Regulation (MDR). Founded in 2013, the company offers end-to-end services including regulatory consultancy, study management, data management, biostatistics, and medical writing. With the MDR's phased implementation and increasing demand for clinical evidence, Archer is well-positioned to capture market share as medical device manufacturers seek expert guidance to navigate complex regulatory requirements. The company's strong local presence in Europe, combined with its niche focus, provides a competitive advantage, though it faces competition from larger global CROs. While specific financials and growth metrics are not publicly available, Archer's specialized expertise and the tailwind from regulatory changes suggest a positive trajectory.
Upcoming Catalysts (preview)
- Q3 2026EU MDR Full Enforcement Deadline Approaches70% success
- TBDMajor Contract Win with Top Medical Device Company40% success
- Q3 2026Expansion of Service Offerings into New EU Markets60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)